US Patent Issued to Abbott Diabetes Care on April 22 for "Sensitivity calibration of in vivo sensors used to measure analyte concentration" (California Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,279,866, issued on April 22, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"Sensitivity calibration of in vivo sensors used to measure analyte concentration" was invented by Erwin Satrya Budiman (Fremont, Calif.) and Gary Alan Hayter (Oakland, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, devices, systems, and computer program products are provided to improve sensitivity calibration of an in vivo analyte sensor and usability of an associated analyte monitoring system. In certain embodiments, methods are provided that improve the user experience of using an analyte monitoring system. Certain embodiments of the present discl...